Torres-Machorro A, Camorlinga-Tagle N, Rodríguez-Ortiz C, Palafox D, González N, López M, Castelán N, de Leo C, Vilatobá M, Gabilondo B, Alberú Gómez J, Morales-Buenrostro L, Granados J
Transplantation Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico.
Transplant Proc. 2010 Jul-Aug;42(6):2372-5. doi: 10.1016/j.transproceed.2010.05.006.
The major histocompatibility complex (MHC) plays a main role in antigen presentation. Class I, II, and III genes form defined "blocks" of conserved DNA sequences (conserved extended haplotypes) that are useful to follow the ancestry of a population. Each variant encodes a specific peptide that determines a particular individual's immune response. In addition, differential expression of HLA antigens in certain physiological and pathological conditions may participate in the pathogenesis of allograft rejection versus tolerance.
The aim of this study was to determine whether the specific HLA ancestry was associated with acute renal graft rejection among the Mexican mestizo population.
We studied 544 Mexican mestizo renal donors and their respective recipients for their serologically determined HLA and based on antigens haplotype assignments. The acute rejection group was compared with the nonrejection group among donors and recipients, correspondingly.
Frequent Mexican alleles were observed in this study. Moreover, HLA-B61/-DR04, HLA-A35/-DR06 (Amerindian ancestry), HLA-A68/-DR01, HLA-A28/-B65/-DR01 (African ancestry), and HLA-A33/-B*65 (Caucasian ancestry) in donors were associated with acute renal graft rejection episodes.
Knowing the ancestry of a donor's HLA molecules may help to individualize immunosuppressive therapy for posttransplant surveillance, because they may be more membrane-exposed in parenchymal cells, making them more susceptible of being recognized by the recipient's immune system.
主要组织相容性复合体(MHC)在抗原呈递中起主要作用。I类、II类和III类基因形成了明确的保守DNA序列“块”(保守扩展单倍型),这对于追踪人群的血统很有用。每个变体编码一种特定的肽,该肽决定了特定个体的免疫反应。此外,HLA抗原在某些生理和病理条件下的差异表达可能参与同种异体移植排斥与耐受的发病机制。
本研究的目的是确定特定的HLA血统是否与墨西哥混血人群中的急性肾移植排斥反应相关。
我们研究了544名墨西哥混血肾供体及其各自的受者,通过血清学方法确定他们的HLA,并基于抗原单倍型分配。相应地,将供体和受者中的急性排斥组与非排斥组进行比较。
在本研究中观察到常见的墨西哥等位基因。此外,供体中的HLA-B61/-DR04、HLA-A35/-DR06(美洲印第安人血统)、HLA-A68/-DR01、HLA-A28/-B65/-DR01(非洲血统)和HLA-A33/-B*65(白种人血统)与急性肾移植排斥反应发作相关。
了解供体HLA分子的血统可能有助于为移植后监测制定个体化的免疫抑制治疗方案,因为它们在实质细胞中可能更多地暴露于细胞膜表面,使其更容易被受者的免疫系统识别。